Results 251 to 260 of about 326,864 (305)

AI in Combating Cyber Threats to Indian Pharmaceutical Intellectual Property: Legal Perspectives.

open access: yesJ Pharm Bioallied Sci
Sharma G   +5 more
europepmc   +1 more source

Pharmaceutical Patent Law: the Canadian Perspective

Pharmaceutical Patent Analyst, 2016
This article provides an overview of the patent regime in Canada, with a focus on issues most relevant to the pharmaceutical industry. The process of applying for a patent is discussed, as well as enforcement and litigation. Recent developments in the case law dealing with patentability requirements - novelty, obviousness, utility and sufficiency - are
Livia, Aumand, John, Norman
openaire   +2 more sources

EU Competition Law and Pharmaceuticals

2022
This timely book discusses the application of the EU competition rules to pharmaceuticals, covering the prohibitions on anticompetitive agreements and abuse of dominance, and merger control. The author team comprises academic experts and private practitioners who analyse recent case law at both EU (and UK) and Member State levels - in the context of ...
Sauter, Wolf   +2 more
openaire   +2 more sources

Pharmaceutical Law

2016
Cet ouvrage transversal traite toutes les connaissances essentielles à acquérir en droit pharmaceutique, aussi bien les aspects scientifiques que législatifs et techniques. Les huit chapitres répondent à toutes les questions se rapportant aux différents produits de santé, à leur définition et à leur réglementation.
openaire   +3 more sources

Law on Pharmaceutical Patents

SSRN Electronic Journal, 2012
India is known as the global pharmaceutical capital because of the ever growing generic drug manufacturing industry. With the growth of such an industry the issue of protection to pharmaceutical patents is also gaining importance. Pharmaceutical patent protection is of prime importance to pharma companies because of the huge amount of money invested in
openaire   +1 more source

Pharmaceutical Law: Criminal Aspects

Gaps in Russian Legislation, 2021
The author, considering the possibility of the emergence of a new branch of law in the future - pharmaceutical law, focuses on the complexity of regulating the sphere of turnover of medicines, at the same time pointing to this as the main reason for the uncertainty of the legislator in matters of the correctness of the choice of the object and subject ...
openaire   +1 more source

Home - About - Disclaimer - Privacy